Alberto Grandi
Siena, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Bacterial Outer Membrane Vesicles as a Platform for the Development of a Broadly Protective Human Papillomavirus Vaccine Based on the Minor Capsid Protein L2.
Journal: Vaccines
Published: September 08, 2023
Immunogenicity and Pre-Clinical Efficacy of an OMV-Based SARS-CoV-2 Vaccine.
Journal: Vaccines
Published: August 09, 2023
Immunogenicity and pre-clinical efficacy of an OMV-based SARS-CoV-2 vaccine.
Journal: Research square
Published: June 09, 2023
Anti-Tumor Efficacy of In Situ Vaccination Using Bacterial Outer Membrane Vesicles.
Journal: Cancers
Published: April 26, 2023
Commensal Bifidobacterium Strains Enhance the Efficacy of Neo-Epitope Based Cancer Vaccines.
Journal: Vaccines
Published: October 08, 2021
Multi-Antigen Outer Membrane Vesicle Engineering to Develop Polyvalent Vaccines: The Staphylococcus aureus Case.
Journal: Frontiers in immunology
Published: August 02, 2021
Proteome-minimized outer membrane vesicles from Escherichia coli as a generalized vaccine platform.
Journal: Journal of extracellular vesicles
Published: May 28, 2020
Bacterial outer membrane vesicles engineered with lipidated antigens as a platform for Staphylococcus aureus vaccine.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 09, 2019
Vaccination With a FAT1-Derived B Cell Epitope Combined With Tumor-Specific B and T Cell Epitopes Elicits Additive Protection in Cancer Mouse Models.
Journal: Frontiers in oncology
Published: July 17, 2018
Last Updated: 09/26/2026